Related Experiment Videos
Labor induction with misoprostol.
1Division of Maternal-Fetal Medicine, Department of Obstetrics-Gynecology, University of Southern California School of Medicine, Los Anageles, California, USA.
American Journal of Obstetrics and Gynecology
|August 24, 1999
Summary
Misoprostol effectively ripens the cervix and induces labor in term pregnancies. Careful use is advised to minimize risks like uterine abnormalities and neonatal acidemia.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Background:
- Misoprostol, a prostaglandin E1 analog, is widely used off-label for cervical ripening and labor induction in the US.
- Its only FDA-approved indication is for intestinal ulcer treatment and prevention.
Purpose of the Study:
- To evaluate the efficacy and safety of misoprostol for cervical ripening and labor induction.
- To investigate optimal dosing, regimens, and routes of administration.
Main Methods:
- Review of multiple clinical trials investigating misoprostol's use in term pregnancy.
- Analysis of data concerning efficacy, adverse events, and delivery outcomes.
Main Results:
- Misoprostol is proven effective for cervical ripening and labor induction.
- Higher doses may correlate with uterine contraction abnormalities, meconium passage, neonatal acidemia, and cesarean delivery for fetal distress.
- Overall, no significant change in cesarean delivery rates was consistently demonstrated.
Conclusions:
- Misoprostol is an effective agent for cervical ripening and labor induction when used judiciously.
- Further research is needed on optimal dosing and administration to balance efficacy and safety.